Pharmacy - Aegrotat Supplementary - Biochemistry Microbiology Immunology - PC 221 - Feb 2022
Pharmacy - Aegrotat Supplementary - Biochemistry Microbiology Immunology - PC 221 - Feb 2022
Pharmacy - Aegrotat Supplementary - Biochemistry Microbiology Immunology - PC 221 - Feb 2022
RHODES UNIVERSITY
FACULTY OF PHARMACY
PAPER 2
INSTRUCTIONS
5) Remember to FILL in the question numbers on the FRONT COVER of your answer
book.
6) ALL answers, including drawings, must be written in ink. Work written in pencil
WILL NOT be marked.
7) Write your student and seat number on Each page of the answer book.
QUESTION 2
(8)
QUESTION 3
Describe the structure of the SARS-CoV-2 virion and virocell. Provide a short and
theoretical justification for your answer.
(8)
QUESTION 4
What are the main structural differences between the virion and the ribovirocell? Provide a
short and theoretical justification for your answer.
(8)
QUESTION 6
Human genes responsible for producing complex biological molecules such as hormones,
enzymes and cytokines can be inserted into bacterial cells. These cells are easily grown to
high cell densities in large volumes and the desired therapeutic materials produced on a large
scale. Using a human-derived gene of interest; bacterial DNA as a plasmid vector and
Escherichia coli as the host bacterium.
Outline and discuss, step by step, how you would make use of the host bacterium machinery
as a mechanism to produce the desired therapeutic materials from the gene of interest on a
large scale. Include all the necessary enzymes involved and materials.
(10)
QUESTION 7
Which is more primitive, innate immunity or adaptive immunity? Justify.
(8)
QUESTION 8
(6)
QUESTION 9
Discuss how the body fights against a bacterial or viral infection. Think about all the probable
mechanisms possible.
(8)
A patient is undergoing the treatment of bacterial infections with an antibiotic drug. For a
while, he was responding to treatment. However, after six months, the patient relapsed: the
infection worsens even when the antibiotic's dosage increases. Based on what you have
learned in class:
(a) Suggest what has led to this possible mechanism that allowed the pathogens to become
resistant to the drug. (8)
(b) What would you propose as a new drug that would target these pathogens? Support
your reasons. (6)
QUESTION 11
Apart from using micro-organisms as synthetic factories for medicines, recombinant DNA
(rDNA) technology is used to produce pharmaceutically useful compounds of biological
origin not produced naturally by microorganisms.